ADAPTIMMUNE THERAPEUTICS PLC Research and Development Expense
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) reported Research and Development Expense of $22.98 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2025-08-13
- ADAPTIMMUNE THERAPEUTICS PLC research and development expense for the quarter ending 2025-06-30 was $22.98M, a 43.19% decline year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC research and development expense for the quarter ending 2025-03-31 was $28.86M, a 18.04% decline year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC research and development expense for the quarter ending 2024-12-31 was $39.10M, a 17.75% increase year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC research and development expense for the quarter ending 2024-09-30 was $34.30M, a 9.22% decline year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC research and development expense for fiscal 2024 was $149.06M, a 17.83% increase from fiscal 2023.
- ADAPTIMMUNE THERAPEUTICS PLC research and development expense for fiscal 2023 was $126.51M, a 0.95% decline from fiscal 2022.
- ADAPTIMMUNE THERAPEUTICS PLC research and development expense for fiscal 2022 was $127.73M, a 14.98% increase from fiscal 2021.
- ADAPTIMMUNE THERAPEUTICS PLC research and development expense for fiscal 2021 was $111.09M, a 21.32% increase from fiscal 2020.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-06-30 | $22.98M 10-Q · filed 2025-08-13 | $51.84M 10-Q · filed 2025-08-13 | $90.94M derived: sum of 3 quarters · filed 2025-08-13 | $125.24M derived: sum of 4 quarters · filed 2025-08-13 | |||
| 2025-03-31 | $28.86M 10-Q · filed 2025-05-13 | $67.96M derived: sum of 2 quarters · filed 2025-05-13 | $102.26M derived: sum of 3 quarters · filed 2025-05-13 | $142.71M derived: sum of 4 quarters · filed 2025-08-13 | |||
| 2024-12-31 | $39.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $73.41M derived: sum of 2 quarters · filed 2025-03-24 | $113.85M derived: sum of 3 quarters · filed 2025-08-13 | $149.06M 10-K · filed 2025-03-24 | |||
| 2024-09-30 | $34.30M 10-Q · filed 2024-11-13 | $74.75M derived: sum of 2 quarters · filed 2025-08-13 | $109.96M 10-Q · filed 2024-11-13 | $143.17M derived: sum of 4 quarters · filed 2025-08-13 | |||
| 2024-06-30 | $40.45M 10-Q · filed 2025-08-13 | $75.66M 10-Q · filed 2025-08-13 | $108.86M derived: sum of 3 quarters · filed 2025-08-13 | $146.65M derived: sum of 4 quarters · filed 2025-08-13 | |||
| 2024-03-31 | $35.21M 10-Q · filed 2025-05-13 | $68.42M derived: sum of 2 quarters · filed 2025-05-13 | $106.20M derived: sum of 3 quarters · filed 2025-05-13 | $136.17M derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | $33.21M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $71.00M derived: sum of 2 quarters · filed 2025-03-24 | $100.96M derived: sum of 3 quarters · filed 2025-03-24 | $126.51M 10-K · filed 2025-03-24 | |||
| 2023-09-30 | $37.79M 10-Q · filed 2024-11-13 | $67.75M derived: sum of 2 quarters · filed 2024-11-13 | $93.30M 10-Q · filed 2024-11-13 | $116.35M derived: sum of 4 quarters · filed 2025-03-24 | |||
| 2023-06-30 | $29.96M 10-Q · filed 2024-08-12 | $55.51M 10-Q · filed 2024-08-12 | $78.56M derived: sum of 3 quarters · filed 2025-03-24 | $111.75M derived: sum of 4 quarters · filed 2025-03-24 | |||
| 2023-03-31 | $25.55M 10-Q · filed 2024-05-15 | $48.60M derived: sum of 2 quarters · filed 2025-03-24 | $81.78M derived: sum of 3 quarters · filed 2025-03-24 | $116.52M derived: sum of 4 quarters · filed 2025-03-24 | |||
| 2022-12-31 | $23.05M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $56.23M derived: sum of 2 quarters · filed 2025-03-24 | $90.97M derived: sum of 3 quarters · filed 2025-03-24 | $127.73M 10-K · filed 2025-03-24 | |||
| 2022-09-30 | $33.18M 10-Q · filed 2023-11-08 | $67.92M derived: sum of 2 quarters · filed 2023-11-08 | $104.67M 10-Q · filed 2023-11-08 | $134.18M derived: sum of 4 quarters · filed 2024-03-06 | |||
| 2022-06-30 | $34.74M 10-Q · filed 2023-08-09 | $71.49M 10-Q · filed 2023-08-09 | $101.00M derived: sum of 3 quarters · filed 2024-03-06 | $129.21M derived: sum of 4 quarters · filed 2024-03-06 | |||
| 2022-03-31 | $36.75M 10-Q · filed 2023-05-12 | $66.26M derived: sum of 2 quarters · filed 2024-03-06 | $94.47M derived: sum of 3 quarters · filed 2024-03-06 | $123.34M derived: sum of 4 quarters · filed 2024-03-06 | |||
| 2021-12-31 | $29.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $57.72M derived: sum of 2 quarters · filed 2024-03-06 | $86.58M derived: sum of 3 quarters · filed 2024-03-06 | $111.09M 10-K · filed 2024-03-06 | |||
| 2021-09-30 | $28.21M 10-Q · filed 2022-11-08 | $57.08M derived: sum of 2 quarters · filed 2022-11-08 | $81.58M 10-Q · filed 2022-11-08 | $107.36M derived: sum of 4 quarters · filed 2023-03-06 | |||
| 2021-06-30 | $28.87M 10-Q · filed 2022-08-04 | $53.37M 10-Q · filed 2022-08-04 | $79.15M derived: sum of 3 quarters · filed 2023-03-06 | $103.22M derived: sum of 4 quarters · filed 2023-03-06 | |||
| 2021-03-31 | $24.51M 10-Q · filed 2022-05-09 | $50.28M derived: sum of 2 quarters · filed 2023-03-06 | $74.35M derived: sum of 3 quarters · filed 2023-03-06 | $94.81M derived: sum of 4 quarters · filed 2023-03-06 | |||
| 2020-12-31 | $25.78M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $49.84M derived: sum of 2 quarters · filed 2023-03-06 | $70.30M derived: sum of 3 quarters · filed 2023-03-06 | $91.57M 10-K · filed 2023-03-06 | |||
| 2020-09-30 | $24.07M 10-Q · filed 2021-11-04 | $44.53M derived: sum of 2 quarters · filed 2021-11-04 | $65.79M 10-Q · filed 2021-11-04 | $86.14M derived: sum of 4 quarters · filed 2022-03-14 | |||
| 2020-06-30 | $20.46M 10-Q · filed 2021-08-09 | $41.72M 10-Q · filed 2021-08-09 | $62.08M derived: sum of 3 quarters · filed 2022-03-14 | $91.69M derived: sum of 4 quarters · filed 2022-03-14 | |||
| 2020-03-31 | $21.26M 10-Q · filed 2021-05-06 | $41.62M derived: sum of 2 quarters · filed 2022-03-14 | $71.23M derived: sum of 3 quarters · filed 2022-03-14 | $96.75M derived: sum of 4 quarters · filed 2022-03-14 | |||
| 2019-12-31 | $20.35M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $49.97M derived: sum of 2 quarters · filed 2022-03-14 | $75.48M derived: sum of 3 quarters · filed 2022-03-14 | $97.50M 10-K · filed 2022-03-14 | |||
| 2019-09-30 | $29.62M 10-Q · filed 2020-11-05 | $55.13M derived: sum of 2 quarters · filed 2020-11-05 | $77.15M 10-Q · filed 2020-11-05 | $99.92M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-06-30 | $25.51M 10-Q · filed 2020-08-06 | $47.53M 10-Q · filed 2020-08-06 | $70.30M derived: sum of 3 quarters · filed 2021-02-25 | $93.78M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-03-31 | $22.02M 10-Q · filed 2020-05-14 | $44.79M derived: sum of 2 quarters · filed 2021-02-25 | $68.27M derived: sum of 3 quarters · filed 2021-02-25 | $94.90M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2018-12-31 | $22.77M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $46.25M derived: sum of 2 quarters · filed 2021-02-25 | $72.88M derived: sum of 3 quarters · filed 2021-02-25 | $98.27M 10-K · filed 2021-02-25 | |||
| 2018-09-30 | $23.48M 10-Q · filed 2019-11-06 | $50.11M derived: sum of 2 quarters · filed 2019-11-06 | $75.50M 10-Q · filed 2019-11-06 | $100.99M derived: sum of 4 quarters · filed 2019-11-06 | |||
| 2018-06-30 | $26.62M 10-Q · filed 2019-08-01 | $52.02M 10-Q · filed 2019-08-01 | $77.50M derived: sum of 3 quarters · filed 2019-08-01 | $101.54M derived: sum of 4 quarters · filed 2019-08-01 | |||
| 2018-03-31 | $25.73M 10-Q · filed 2019-05-06 | $50.88M derived: sum of 2 quarters · filed 2019-05-06 | $74.91M derived: sum of 3 quarters · filed 2019-05-06 | $94.50M derived: sum of 4 quarters · filed 2019-05-06 | |||
| 2017-12-31 | $25.15M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $49.18M derived: sum of 2 quarters · filed 2019-02-27 | $68.77M derived: sum of 3 quarters · filed 2019-02-27 | $87.39M 10-K · filed 2019-02-27 | |||
| 2017-09-30 | $24.03M 10-Q · filed 2018-11-06 | $43.63M derived: sum of 2 quarters · filed 2018-11-06 | $62.24M 10-Q · filed 2018-11-06 | $79.09M derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2017-06-30 | $19.59M 10-Q · filed 2018-08-02 | $38.21M 10-Q · filed 2018-08-02 | $55.05M derived: sum of 3 quarters · filed 2019-02-27 | $70.66M derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2017-03-31 | $18.61M 10-Q · filed 2018-05-09 | $35.46M derived: sum of 2 quarters · filed 2019-02-27 | $51.07M derived: sum of 3 quarters · filed 2019-02-27 | $67.93M derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2016-12-31 | $16.85M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $32.46M derived: sum of 2 quarters · filed 2019-02-27 | $49.31M derived: sum of 3 quarters · filed 2019-02-27 | $63.79M 10-K · filed 2019-02-27 | |||
| 2016-09-30 | $15.61M 10-Q · filed 2017-11-02 | $32.47M derived: sum of 2 quarters · filed 2017-11-02 | $46.94M 10-Q · filed 2017-11-02 | $63.56M derived: sum of 4 quarters · filed 2018-03-15 | |||
| 2016-06-30 | $16.86M 10-Q · filed 2017-08-03 | $16.22M 10-Q · filed 2016-08-08 | $31.33M 10-Q · filed 2017-08-03 | $30.11M 10-Q · filed 2016-08-08 | $47.95M derived: sum of 3 quarters · filed 2018-03-15 | $56.80M derived: sum of 4 quarters · filed 2018-03-15 | |
| 2016-03-31 | $14.48M 10-Q · filed 2017-05-10 | $13.89M 10-Q · filed 2016-05-12 | $31.09M derived: sum of 2 quarters · filed 2018-03-15 | $39.95M derived: sum of 3 quarters · filed 2018-03-15 | $48.35M derived: sum of 4 quarters · filed 2018-03-15 | ||
| 2015-12-31 | $16.62M derived: 10-K 6 month − 10-Q 3 month · filed 2018-03-15 | $25.47M 10-K · filed 2018-03-15 | $24.24M 10-Q · filed 2016-05-12 | $33.88M derived: sum of 3 quarters · filed 2018-03-15 | $39.85M derived: sum of 4 quarters · filed 2018-03-15 | ||
| 2015-09-30 | $8.85M 10-Q · filed 2016-11-10 | $17.26M derived: sum of 2 quarters · filed 2016-11-10 | $23.84M 10-Q · filed 2016-11-10 | ||||
| 2015-06-30 | $8.40M 10-Q · filed 2016-08-08 | $14.38M 10-Q · filed 2016-08-08 | $24.14M 10-K · filed 2018-03-15 | $23.28M 8-K · filed 2016-07-08 | |||
| 2015-03-31 | $5.98M 10-Q · filed 2016-05-12 | ||||||
| 2014-06-30 | $9.57M 10-K · filed 2017-03-13 | $9.75M 8-K · filed 2016-07-08 | |||||
| 2013-06-30 | $7.50M 8-K · filed 2016-07-08 |